Radiation-proof medical protective glove and production process thereof

By using polydopamine hollow microspheres prepared by the ZIF-8 self-sacrificial template method to load bismuth oxide and gadolinium elements in anti-radiation gloves, and combining them with nano-starch crosslinking network and plasma etching technology, the problems of weight, flexibility and breathability of traditional gloves have been solved, achieving high-efficiency anti-radiation performance and comfortable wear.

CN121895606APending Publication Date: 2026-04-21CHANGSHU NO 2 PEOPLES HOSPITAL +1

Patent Information

Application Number
CN202610113291.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-01-28
Publication Date
2026-04-21

AI Technical Summary

Technical Problem

Traditional lead-based radiation protection gloves are heavy and lack flexibility, while flexible composite material gloves suffer from filler agglomeration and poor breathability, affecting wearing comfort and the consistency of protection.

Method used

Polydopamine hollow microspheres loaded with bismuth oxide and gadolinium were prepared using the ZIF-8 self-sacrificial template method. Combined with nano-starch crosslinking network and mask-assisted plasma etching technology, shielding function, mechanical reinforcement and surface unidirectional moisture conduction function were constructed to achieve uniform dispersion of filler and moisture management.

Benefits of technology

It achieves lightweight, flexible, and comfortable radiation protection performance, improving the protective ability and wearing comfort of protective gloves, and is especially suitable for highly flexible scenarios such as interventional radiology surgery.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

The invention discloses an anti-radiation medical protective glove and a production process thereof, and belongs to the technical field of medical protective gloves, a polydopamine hollow microsphere is prepared by using ZIF-8 as a self-sacrifice template, bismuth and gadolinium elements are loaded through hydrothermal synthesis and ion adsorption, a composite shielding microsphere is prepared, and the composite shielding microsphere is used for preparing the anti-radiation medical protective glove. Then, the composite shielding microspheres and a nano starch enhanced cross-linked network are synergistically introduced into a natural latex matrix, after dipping forming, a hydrophilic / hydrophobic wetting gradient is constructed on a glove lining through mask auxiliary plasma etching, and the anti-radiation medical protective glove is prepared. Through the cooperation of the shielding function of the composite microspheres, the mechanical enhancement of a nano starch cross-linked network and the surface one-way moisture conduction function, the glove has excellent radiation protection performance and also has the characteristics of being light, flexible and comfortable to wear, the problems that a traditional lead rubber glove is heavy, rigid and poor in air permeability are effectively solved, and the service life of the glove is prolonged. The system is especially suitable for medical scenes requiring high flexibility and comfort, such as interventional radiosurgery.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of medical protective gloves technology, specifically a radiation-proof medical protective glove and its manufacturing process. Background Technology

[0002] Radiation-protective medical gloves are a key component of personal protective equipment (PPE), widely used in scenarios involving ionizing radiation exposure, such as medical radiology, nuclear medicine, industrial testing, and scientific research experiments. With the increasing prevalence of interventional radiotherapy and precision radiotherapy techniques, the hands of medical personnel often become the front line of radiation exposure, facing the potential risk of cumulative damage. Developing high-performance protective gloves is crucial for ensuring occupational health.

[0003] Traditional radiation protection gloves are mainly made of lead or its composite materials, utilizing lead's photoelectric effect and Compton scattering to attenuate X-ray and gamma-ray energy. However, this design has problems such as heavy weight, poor flexibility, and potential toxicity, which seriously affect the operational flexibility and wearing comfort of medical personnel. To overcome the shortcomings of traditional lead gloves, flexible composite material radiation protection gloves have gradually become a research hotspot.

[0004] Flexible composite radiation protection gloves use high atomic number metal powder or metal oxide as shielding components, which are dispersed in polymer matrices such as chloroprene rubber, nitrile rubber, and silicone rubber. Compared with traditional lead gloves, flexible composite gloves have advantages such as light weight, good flexibility, and environmental friendliness. However, nanoscale shielding fillers are prone to agglomeration and sedimentation in polymer matrices. Agglomeration leads to uneven filler distribution, reducing the consistency of protection. At the same time, filler agglomeration may weaken the mechanical properties of the matrix, reduce tear resistance, and affect the durability of the gloves.

[0005] To address the issue of filler agglomeration, Chinese patent application CN116444873A discloses a radiation-shielding material and its preparation method. This method utilizes fullerol as a dispersant and crosslinking agent to create an ordered structure, achieving uniform distribution of radiation-shielding high atomic number fillers and solving the problem of filler agglomeration in traditional composite materials.

[0006] However, while this method solves the problem of filler agglomeration, the resulting dense cross-linked network structure may restrict the breathability and moisture permeability of the material. In addition, for protective composite materials with high filler content, the high density distribution of filler particles in the matrix can also easily affect the inherent porous structure of the latex, which may hinder the dissipation of sweat. During long-term wear, internal heat and moisture accumulate, which can easily lead to stuffiness and affect wearing comfort, thus limiting its application in medical scenarios that require long-term operation. Summary of the Invention

[0007] The purpose of this invention is to provide a radiation-proof medical protective glove and its manufacturing process. Through the synergistic effect of the shielding function of composite microspheres, the mechanical reinforcement of nano starch cross-linked network and the surface unidirectional moisture-wicking function, the glove has excellent radiation protection performance while also being lightweight, flexible and comfortable to wear. It effectively solves the problems of traditional lead rubber gloves being bulky, stiff and having poor breathability, and is especially suitable for medical scenarios that require high flexibility and comfort, such as interventional radiology surgery.

[0008] The objective of this invention can be achieved through the following technical solutions: A manufacturing process for radiation-proof medical protective gloves, characterized by comprising the following steps: Step 1: Using ZIF-8 as a self-sacrificing template, bismuth oxide was sequentially loaded onto polydopamine hollow microspheres and gadolinium was adsorbed through polymerization and hydrothermal synthesis to obtain composite shielding microspheres.

[0009] Step 2: The composite shielding microspheres are mixed with nano starch solution prepared by alkali-urea gelatinization, sodium carboxymethyl cellulose and PAE crosslinking agent in natural latex, and then the mixture is prepared as a semi-finished glove through an impregnation molding process.

[0010] Step 3: Using mask-assisted atmospheric pressure plasma etching technology, selective etching is performed on the inner lining surface of the glove semi-finished product to construct a one-way moisture-wicking structure, thus producing radiation-proof medical protective gloves.

[0011] Furthermore, the mask-assisted atmospheric pressure plasma etching method is as follows: The semi-finished glove is immersed in an ethanol solution containing PDMS prepolymer and PDMS curing agent, and then uniformly pulled at a speed of 100 mm / min. It is cured at room temperature for 1 hour. A flexible mask is tightly attached to the surface of the glove lining. The area covering the mask is etched using an atmospheric pressure plasma treatment device. The mask is then removed, rinsed with deionized water, and dried at 40°C for 1-2 hours to obtain radiation-proof medical protective gloves.

[0012] Furthermore, the ratio of PDMS prepolymer, PDMS curing agent and ethanol solution is 2-3g: 0.25-0.3g: 80-120mL.

[0013] Furthermore, the parameters of the atmospheric pressure plasma equipment are set as follows: power of 300W, oxygen as the process gas, etching distance of 30-40mm, and processing time of 120-150s.

[0014] Furthermore, the specific preparation steps for the semi-finished gloves are as follows: Preheat the glove mold at 60-80℃ for 25-35 minutes, then immerse the glove mold in a 2% calcium acetate solution. After removing it, dry it at 60℃ for 4-6 minutes. Next, slowly immerse it in the composite latex and gently lift it out. Initially dry it at 40℃ for 1-2 hours, then increase the temperature to 85-90℃ at a rate of 1℃ / min and cure it at 85-90℃ for 100-140 minutes. After curing, peel the glove off the mold, wash it with deionized water at 40℃, and finally dry it at 40℃ to constant weight to obtain the semi-finished glove.

[0015] Furthermore, the specific preparation steps of the composite latex are as follows: Natural latex was added to a reaction vessel and stirred at 400-600 r / min. Nano starch solution and sodium carboxymethyl cellulose were added to the vessel in sequence and stirred for 5 min. Then, a crosslinking agent ARK-889 solution with a pH of 10 was added and stirred for 30 min. Composite shielding microspheres were slowly added and dispersed at 800-1000 r / min for 10 min to obtain composite latex.

[0016] Furthermore, the ratio of natural latex, nano starch solution, sodium carboxymethyl cellulose, crosslinking agent ARK-889 solution, and composite shielding microspheres is 95-105mL: 4-6g: 1.5-2.5g: 5-10mL: 0.4-0.6g.

[0017] Furthermore, the specific preparation steps of the nano-starch solution are as follows: Tapioca starch and 25% wt ammonia water were added to a stirred tank, mixed and dispersed. Sodium hydroxide, urea and deionized water were then added to the tank. The mixture was stirred and gelatinized at 80-90℃ for 40 min. The reaction system was then transferred to an ice-water bath to cool and sonicated until the solution was clear and transparent. After equilibration to room temperature, nano starch solution was obtained.

[0018] Furthermore, the ratio of cassava starch, ammonia, sodium hydroxide, urea, and deionized water is 8-12g: 15-25mL: 3-5g: 12-16mL: 125-140mL.

[0019] Furthermore, the specific preparation steps of the composite shielding microspheres are as follows: Polydopamine / bismuth oxide composite microspheres and deionized water were added to a reaction vessel and stirred at 200-400 r / min. A gadolinium nitrate solution with a concentration of 0.01 mol / L was added to the vessel, and stirring was continued for 6-12 h. Samples were taken at regular intervals, and the supernatant was centrifuged to detect the gadolinium ion concentration. The reaction was terminated when the concentration reached adsorption equilibrium. After the reaction was completed, the mixture was filtered, rinsed with deionized water, and dried to obtain composite shielding microspheres.

[0020] Furthermore, the ratio of polydopamine / bismuth oxide composite microspheres, deionized water, and gadolinium nitrate solution is 0.25-0.35g: 180-220mL: 0.8-1.2mL.

[0021] Furthermore, the specific preparation steps of the polydopamine / bismuth oxide composite microspheres are as follows: Polydopamine hollow microspheres, urea, deionized water, and bismuth nitrate acid solution were placed in a polytetrafluoroethylene stainless steel high-pressure reactor and reacted at 150-170℃ for 2-4 hours. After the reaction was completed, the mixture was cooled to room temperature, washed with deionized water and ethanol, centrifuged, and the filter cake was vacuum dried at 60℃ for 10-14 hours to obtain polydopamine / bismuth oxide composite microspheres.

[0022] Furthermore, the ratio of polydopamine hollow microspheres, urea, deionized water, and bismuth nitrate acidic solution is 0.1-0.2g: 0.7-0.9g: 35-45mL: 5mL.

[0023] Furthermore, the specific preparation steps of polydopamine hollow microspheres are as follows: ZIF-8 powder was dispersed in methanol and added to a reaction vessel along with a 0.25 mol / L dopamine hydrochloride methanol solution. The reaction was carried out at 55 °C for 4 h. After the reaction was completed, the product was centrifuged, washed with methanol, and dried under vacuum at 40 °C for 10-14 h. The product was then ground and sieved to obtain polydopamine hollow microspheres.

[0024] Furthermore, the ratio of ZIF-8 powder, methanol, and dopamine hydrochloride methanol solution is 8-12g: 650-750mL: 650-750mL.

[0025] The beneficial effects of this invention are: 1. This invention constructs a bismuth / gadolinium composite shielding system using polydopamine hollow microspheres as a carrier, combined with a cross-linked network reinforced by nano-starch and mask-assisted plasma etching technology. This achieves highly dispersed and uniform protection of the filler while effectively improving the overall moisture management capability of the material. Through the synergy of matrix hydrophilic modification and surface wetting gradient construction, this design significantly improves sweat conduction efficiency and reduces the risk of skin immersion and microbial growth caused by prolonged wear, thereby ensuring the continuous comfort and safety of the protective gloves in clinical settings.

[0026] 2. The polydopamine hollow microspheres prepared by the ZIF-8 self-sacrificial template method in this invention play a dual pivotal role of "structure-function" in the composite microsphere system. The hollow structure not only significantly increases the specific surface area and effectively improves the loading of high atomic number elements such as bismuth and gadolinium, but also endows the microspheres with lightweight properties. The internal cavity and surface pores provide additional channels for moisture transfer, enhancing the permeability of the matrix. They exhibit complementary characteristics in broadband radiation protection, and their composite use further broadens the protection range and enhances the overall shielding performance. At the same time, the catechol and amino functional groups contained in the polydopamine layer not only stabilize and anchor the radiation protection components through coordination bonds, but also react with the epoxy groups of the PAE crosslinking agent during the latex crosslinking process, enabling the microspheres to actively embed and strengthen the three-dimensional network. This not only achieves uniform dispersion of fillers and prevents agglomeration and sedimentation, but also further improves the interfacial bonding strength and functional durability.

[0027] In addition, the hydrophilic properties of polydopamine are further activated after plasma etching, which synergistically enhances the stability and moisture-wicking efficiency of the surface hydrophilic channels. Its inherent antibacterial properties also effectively reduce the risk of microbial growth on the glove lining surface. While maintaining excellent protective performance, it provides multi-dimensional support for overall wearing comfort and hygiene safety.

[0028] 3. In this invention, the nano-starch obtained by alkali-urea gelatinization combined with ultrasonic treatment plays a role in mechanical reinforcement and moisture control within the system. The large number of hydroxyl groups exposed after depolymerization not only significantly improve the tensile strength and elongation at break of the gloves by constructing a dense three-dimensional interpenetrating network with sodium carboxymethyl cellulose (CMC) and PAE crosslinking agent, but more importantly, these hydrophilic groups endow the matrix with intrinsic hygroscopic and moisturizing properties, providing a basis for the migration of internal moisture to the surface. In addition, the introduction of nano-starch optimizes the spatial distribution of the crosslinking network. Its flexible molecular chains coordinate with the rigid crosslinking points formed by PAE, ensuring mechanical properties while avoiding embrittlement caused by excessive crosslinking, thus giving the gloves both toughness and elasticity. The multi-component synergy of nano-starch, CMC, and PAE achieves a unity of mechanical strength, moisture management, and material flexibility.

[0029] 4. In this invention, the mask-assisted plasma etching process creates a two-dimensional planar wettability difference structure by constructing hydrophilic and hydrophobic regions on the surface of the glove lining. This surface characteristic, combined with the hydrophilic matrix modified with nano starch, works together to manage moisture during use: the matrix material helps absorb and diffuse sweat to the lining surface. When sweat reaches the surface, the surface characteristic difference between the hydrophilic and hydrophobic regions helps guide the sweat to spread mainly along the surface, thereby promoting its evaporation and helping to keep the contact area dry. This multi-level moisture management mechanism from bulk phase to interface ensures the rapid conduction and evaporation of sweat and avoids local accumulation. Detailed Implementation

[0030] The technical solutions of the present invention will be clearly and completely described below with reference to the embodiments of the present invention. Obviously, the described embodiments are only some embodiments of the present invention, and not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative effort are within the scope of protection of the present invention.

[0031] Example 1: A manufacturing process for radiation-proof medical protective gloves S1: Place 50 mL of 0.025 mol / L 2-methylimidazolium methanol solution and 50 mL of 0.025 mol / L zinc nitrate hexahydrate methanol solution in a reaction vessel, stir thoroughly for 5 min, and then let stand for 45 min. After the reaction is complete, centrifuge the mixture and wash the precipitate with methanol. Repeat this operation 3 times. Collect the precipitate and dry it at 60℃ to obtain ZIF-8 powder.

[0032] 10g of ZIF-8 powder was dispersed in 700mL of methanol and added to a reaction vessel along with 700mL of 0.25mol / L dopamine hydrochloride methanol solution. The reaction was carried out at 55℃ for 4h. After the reaction was completed, the precipitate was collected by centrifugation, washed repeatedly with methanol, and vacuum dried at 40℃ for 12h. The dried product was then lightly ground in an agate mortar and sieved through a 300-mesh standard sieve to obtain polydopamine hollow microspheres.

[0033] This step employs a self-sacrificing template method, using ZIF-8 as a self-sacrificing template. Under mild conditions, dopamine monomers are guided to undergo oxidative polymerization on their surface, forming a polydopamine shell. Simultaneously, the catechol groups in the polydopamine molecules strongly chelate zinc ions in the ZIF-8 framework, causing the template to decompose spontaneously, ultimately yielding polydopamine microspheres with a hollow structure.

[0034] S2: Dissolve 0.28g of bismuth nitrate pentahydrate in 5mL of 0.5mol / L dilute nitric acid to prepare an acidic bismuth nitrate solution; place 0.15g of polydopamine hollow microspheres, 0.8g of urea, 40mL of deionized water and 5mL of the entire acidic bismuth nitrate solution in a stainless steel high-pressure reactor lined with polytetrafluoroethylene, and react at 160℃ for 3h. After the reaction is completed, allow it to cool naturally to room temperature, wash the product with deionized water and ethanol, centrifuge, and vacuum dry the filter cake at 60℃ for 12h to obtain polydopamine / bismuth oxide composite microspheres.

[0035] 0.3 g of polydopamine / bismuth oxide composite microspheres and 200 mL of deionized water were added to a reaction vessel and stirred at 200-400 r / min. 1 mL of 0.01 mol / L gadolinium nitrate solution was added to the vessel and the mixture was stirred continuously for 8 h. Samples were taken periodically during the reaction. After centrifugation, the supernatant was collected and the gadolinium ion concentration was measured. The reaction was terminated when the concentration reached adsorption equilibrium. After the reaction was completed, the mixture was filtered, rinsed with deionized water to remove unadsorbed free ions, and dried to obtain the composite shielding microspheres.

[0036] The preparation process is based on a two-step continuous surface functionalization reaction: First, under hydrothermal conditions, ammonia and carbon dioxide released from the decomposition of urea dissolve in water to form ammonium carbonate / ammonium bicarbonate, making the system weakly alkaline. This allows bismuth ions generated by the ionization of bismuth nitrate in the solution to combine with hydroxide ions to form bismuth oxide precipitate. Simultaneously, the catechol and amino functional groups abundant on the surface of polydopamine microspheres preferentially chelate and fix bismuth ions, guiding the in-situ nucleation and uniform growth of bismuth oxide on the microsphere surface, forming polydopamine / bismuth oxide composite microspheres. Subsequently, in the ion adsorption stage, gadolinium ions in the gadolinium nitrate solution coordinate with the active groups of polydopamine on the surface of the composite microspheres and the hydroxyl groups of the bismuth oxide already loaded, achieving a strong loading of gadolinium through stable coordination bonds, ultimately constructing composite shielding microspheres.

[0037] S3: Add 10g of cassava starch and 20mL of 25% ammonia water to a stirred tank, mix and disperse. Then add 4g of sodium hydroxide, 14mL of urea and 132g of deionized water to the tank. Stir and gelatinize at 85℃ for 40min. Then transfer the reaction system to an ice-water bath to cool and sonicate until the solution becomes clear and transparent. After equilibration to room temperature, nano starch solution is obtained.

[0038] 100 mL of natural latex was added to a reaction vessel and stirred at 500 r / min. 5 g of nano starch solution and 2 g of sodium carboxymethyl cellulose (CMC) were slowly added to the vessel and stirred for 5 min to make it initially uniform. Then, 8 mL of crosslinking agent ARK-889 (PAE) solution with a pH of 10 was added and stirred for 30 min until the viscosity of the system increased significantly. 0.5 g of composite shielding microspheres were then slowly added and dispersed for 10 min at a speed of 1000 r / min to obtain composite latex.

[0039] Based on the precise control of multi-component sequential addition and synergistic reaction: First, cassava starch is gelatinized through an alkali-urea system combined with ultrasonic treatment, efficiently deconstructing it into nanoscale, fully exposing hydroxyl groups, and enhancing the hydrophilicity and dispersibility of the system; Second, natural latex undergoes a directional crosslinking reaction with CMC and PAE, where the carboxyl groups of CMC and the epoxy groups of PAE form stable β-hydroxy ester bonds through ring-opening, constructing a three-dimensional network to improve mechanical strength; Then, composite shielding microspheres are ultrasonically dispersed in the system, and the quinone and amino functional groups rich in the polydopamine layer on their surface can react with the epoxy groups of the PAE crosslinking agent, thereby firmly anchoring the microspheres to the three-dimensional network of the latex through covalent bonds, achieving uniform and stable loading. This composite system lays the matrix foundation for subsequent efficient lateral sweat management through surface modification.

[0040] S4: Preheat the glove mold at 70℃ for 30 minutes, then immerse the glove mold in a 2% calcium acetate coagulant solution. After removing it, dry it at 60℃ for 5 minutes, then slowly immerse it in the composite latex and gently lift it out. Initially dry it at 40℃ for 1 hour, then increase the temperature to 90℃ at a rate of 1℃ / min and cure it at 90℃ for 120 minutes. After curing, peel the glove off the mold, wash it with deionized water at 40℃ for 40 minutes, and finally dry it at 40℃ to constant weight to obtain the final glove semi-finished product.

[0041] After the preheated mold is impregnated with calcium acetate coagulant, the calcium ions on its surface can neutralize the surface charge of the latex particles, triggering demulsification and coagulation, causing the rubber polymer to deposit and form a uniform wet film. After initial low-temperature drying to fix the shape, the latex molecular chains are stimulated to undergo vulcanization and cross-linking reaction at high temperature, constructing a stable three-dimensional network structure, giving the glove semi-finished product excellent mechanical properties, elasticity and durability. Finally, washing removes residual impurities to ensure the product's biosafety and user comfort.

[0042] S5: Immerse the semi-finished glove in 100mL of ethanol solution containing 2.5g of PDMS prepolymer and 0.25g of PDMS curing agent, and pull it up at a uniform speed of 100mm / min. Cure at room temperature for 1h to form a hydrophobic coating on the surface. Fit the flexible mask tightly to the inner surface of the glove, ensuring that it fits completely with the curved surface of the glove. Use an atmospheric pressure plasma treatment device, introduce oxygen as the process gas, and etch the area covering the mask for 150s under the conditions of 300W power and 40mm etching distance. After treatment, remove the mask, rinse with deionized water to remove residues, and dry at 40℃ for 1-2h to obtain radiation-proof medical protective gloves.

[0043] A mask-assisted atmospheric pressure plasma etching process is used to achieve area-selective treatment on the surface of the glove liner: through the spatial confinement effect of a flexible mask with a regular array of micropores, the highly reactive oxygen plasma can only etch the PDMS coating in the exposed areas, efficiently removing the hydrophobic silane components on the surface and introducing hydrophilic functional groups, thereby forming an ordered lattice of hydrophilic channels, while the PDMS coating in the mask-covered areas retains its complete superhydrophobicity. This creates a two-dimensional surface wetting difference on the glove liner surface, consisting of a hydrophilic lattice and a hydrophobic background. When sweat comes into contact with the surface, this structure can guide the sweat to spread laterally from the hydrophilic area to the hydrophobic area in the two-dimensional plane, thereby accelerating evaporation and keeping the surface dry.

[0044] Example 2-Example 3: A production process for radiation-proof medical protective gloves. The difference from Example 1 is that the amount of substance added in step S2 is different, while the other steps and parameters remain the same. The specific amounts added are shown in Table 1 below.

[0045] Table 1. Comparison of the amount of substances used in step S2 Example 4-Example 5: A production process for radiation-proof medical protective gloves. The difference from Example 1 is that the amount of substance added in step S3 is different, while the other steps and parameters remain the same. The specific amounts added are shown in Table 2 below.

[0046] Table 2 Comparison of Substance Amounts in Step S3 Example 6: A production process for radiation-proof medical protective gloves, which differs from Example 1 in that the parameters of the atmospheric pressure plasma treatment equipment in step S5 are set as follows: power of 300W, oxygen is introduced as the process gas, and etching distance is 30mm. The area covered by the mask is etched for 120s. The remaining steps and parameters are the same.

[0047] All materials and reagents used in Examples 1-6 of this application are commercially available products. Urea, gadolinium nitrate, calcium acetate (coagulant), and sodium carboxymethyl cellulose were purchased from Shanghai Maclean Biochemical Technology Co., Ltd.; 2-methylimidazole, zinc nitrate hexahydrate, dopamine hydrochloride, bismuth nitrate pentahydrate, and 25%wt analytical grade ammonia were purchased from Shanghai Aladdin Biochemical Co., Ltd.; cassava starch was an industrial-grade product provided by Jinan Lufeng Cassava Starch Co., Ltd.; natural latex was a high-ammonia concentrated type with a total solids content ≥60%, supplied by Xingyu New Materials Co., Ltd.; crosslinking agent ARK-889 (PAE) was supplied by Shanghai Ankerman Chemical Co., Ltd.; silicone rubber sheets were purchased from Jiangsu Gefang New Materials Co., Ltd., with a thickness of 0.2mm, and were laser-engraved into a regular porous array flexible mask with a pore size of 1.5mm and a pore spacing of 7mm; the PDMS prepolymer and curing agent used were Sylgard-184 products from Dow Chemical Company, USA; surface treatment was performed using Plasmatreater AS (Germany). The 400-type atmospheric pressure plasma treatment equipment has been completed.

[0048] Comparative Example 1: Based on Example 1, the preparation of composite shielding microspheres in steps S1-S2 was omitted, and no radiation-proof filler was added in step S3. The remaining steps and parameters remained the same, and radiation-proof medical protective gloves were obtained.

[0049] Comparative Example 2: Based on Example 1, the composite shielding microspheres in step S3 were replaced with an equal amount of traditional lead powder, while the remaining steps and parameters remained the same, to obtain radiation-proof medical protective gloves.

[0050] Comparative Example 3: Based on Example 1, the plasma etching process in step S5 was omitted, while the remaining steps and parameters remained the same, and radiation-proof medical protective gloves were obtained.

[0051] The radiation-protective medical gloves prepared in Examples 1-6 and Comparative Examples 1-3 were cut into standard samples for performance testing. The radiation protection performance was evaluated by lead equivalent, which was determined according to the method specified in IEC 61331-3:2014. The test conditions were: tube voltage 60kV, total filtration 2.5mm Al, and narrow beam geometry. The results were characterized by equivalent lead thickness (mmPb). The higher the value, the higher the protection level against 60kV X-rays.

[0052] Mechanical property tests include tensile strength and elongation at break, which are determined according to the methods specified in GB / T 528-2009. Dumbbell-shaped specimens are used, and the tests are completed at room temperature and a tensile speed of 500 mm / min. The higher the tensile strength result, the stronger the material's resistance to failure, and the higher the elongation at break result, the better the material's flexibility.

[0053] The weight of the gloves was measured using an electronic balance with an accuracy of 0.1g. The smaller the value, the lighter the wearing load.

[0054] Breathability and moisture permeability are determined according to the method specified in GB / T 12704.1-2009 standard. The water vapor transmission rate is evaluated to reflect its heat dissipation and perspiration wicking ability. The higher the value, the better the breathability and comfort.

[0055] All test results are the average of three measurements, and the test results are shown in Table 3.

[0056] Table 3 Performance test results of various medical protective gloves As shown in Table 3, Examples 1-6 used composite shielding microspheres as shielding fillers, combined with nano-starch-enhanced cross-linked networks and mask-assisted plasma etching technology, successfully achieving a balance and unity between high protection, excellent mechanical properties and outstanding wearing comfort of the radiation protection gloves.

[0057] Examples 2-3 optimized the structure and elemental loading of the composite microspheres by adjusting the amounts of polydopamine hollow microspheres, urea, and gadolinium nitrate solution in step S2, effectively improving the performance and loading efficiency of the shielding filler, thereby enhancing the radiation protection capability of the gloves. Simultaneously, it ensured good compatibility between the filler and the polymer matrix, avoiding adverse effects on the material's flexibility due to filler addition. Examples 4-5 adjusted the crosslinking density of the latex matrix by adjusting the amounts of nano-starch solution and crosslinking agent in step S3, significantly improving the mechanical strength and toughness of the latex material. This optimized three-dimensional network structure gives the gloves superior durability and tear resistance, extending the product's lifespan. Example 6 optimized the surface etching process parameters, adjusting the etching distance in step S5 to 30mm and shortening the time to 120s, constructing a more efficient hydrophilic moisture-wicking channel on the inner lining surface of the gloves. This improvement greatly enhances the gloves' breathability and sweat-wicking ability, significantly improving comfort during prolonged wear and effectively solving the problem of stuffiness and dampness in traditional protective gloves.

[0058] The lead equivalent of the sample in Comparative Example 1 was the lowest among all groups, far below the medical protection standard (which usually requires a lead equivalent ≥0.25 mmPb). This may be because the composite microsphere preparation process in steps S1-S2 was omitted, and no radiation-shielding filler was added in step S3. As a result, the gloves lacked high atomic number shielding components, and the glove matrix relied solely on the polymer itself for extremely limited radiation attenuation, leading to the failure of its radiation protection performance and lack of protective value for clinical applications.

[0059] The tensile strength and elongation at break of the sample in Comparative Example 2 were significantly lower than those in all examples, and the weight of a single glove was much greater than that in the examples. The water vapor permeability was also poor. This may be because replacing the composite shielding microspheres in step S3 with an equal amount of traditional lead powder has several drawbacks. Firstly, the density of lead powder is much higher than that of the composite microspheres of this invention, leading to a significant increase in the weight of the finished glove and increasing the wearing load. Secondly, rigid lead powder easily becomes a stress concentration point in the matrix, weakening the bonding force between polymer molecular chains, resulting in decreased flexibility and durability. Simultaneously, the dense lead powder particles severely clog the inherent pores of the latex, hindering water vapor permeability and making the gloves stuffy. This result confirms the inherent defects of traditional lead materials in terms of lightweighting, flexibility, and comfort.

[0060] The water vapor transmission rate of the sample in Comparative Example 3 was significantly lower than that of most embodiments. This may be because the plasma etching process in step S5 was omitted, resulting in the formation of a complete PDMS hydrophobic coating on the surface of the glove lining instead of the preset hydrophilic / hydrophobic alternating lattice structure. This hydrophobic coating hinders the dissipation of water vapor, thereby reducing the material's moisture permeability. More importantly, the surface lacks a two-dimensional wetting gradient composed of hydrophilic and hydrophobic regions, making it impossible to drive sweat to spread laterally through differential capillary effect, thus losing the unidirectional moisture-wicking function. Therefore, sweat easily accumulates between the skin and the lining, causing stuffiness and discomfort when wearing the gloves. This result confirms the key role of mask-assisted plasma etching process in constructing a functional wetting surface and improving the heat dissipation and sweat-wicking capacity of high-protection gloves.

[0061] It should be noted that, in this document, terms such as “comprising,” “including,” or any other variations thereof are intended to cover non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements includes not only those elements but also other elements not expressly listed, or elements inherent to such process, method, article, or apparatus.

[0062] Although embodiments of the invention have been shown and described, it will be understood by those skilled in the art that various changes, modifications, substitutions and alterations can be made to these embodiments without departing from the principles and spirit of the invention.

Claims

1. A manufacturing process for radiation-proof medical protective gloves, characterized in that, Prepared by the following steps: Step 1: Using ZIF-8 as a self-sacrificing template, bismuth oxide was sequentially loaded onto polydopamine hollow microspheres and gadolinium was adsorbed through polymerization and hydrothermal synthesis to obtain composite shielding microspheres; Step 2: The composite shielding microspheres are mixed with nano starch solution prepared by alkali-urea gelatinization, sodium carboxymethyl cellulose and PAE crosslinking agent in natural latex, and the mixture is then prepared as a semi-finished glove through an impregnation molding process. Step 3: The semi-finished glove is processed by mask-assisted atmospheric pressure plasma etching. Selective etching is performed on the inner lining surface of the semi-finished glove to construct a one-way moisture-wicking structure and obtain radiation-proof medical protective gloves.

2. The manufacturing process of a radiation-proof medical protective glove according to claim 1, characterized in that, The mask-assisted atmospheric pressure plasma etching method is as follows: The semi-finished glove is immersed in an ethanol solution containing PDMS prepolymer and PDMS curing agent, and then uniformly lifted at a speed of 100 mm / min. It is cured at room temperature for 1 hour. The flexible mask is tightly attached to the surface of the glove lining. The area covered by the mask is etched using an atmospheric pressure plasma treatment device. The mask is then removed, rinsed with deionized water, and dried at 40°C for 1-2 hours to obtain radiation-proof medical protective gloves. The ratio of the amount of PDMS prepolymer, PDMS curing agent and ethanol solution is 2-3g: 0.25-0.3g: 80-120mL.

3. The manufacturing process of a radiation-proof medical protective glove according to claim 2, characterized in that, The parameters of the atmospheric pressure plasma equipment are set as follows: power of 300W, oxygen as process gas, etching distance of 30-40mm, and processing time of 120-150s.

4. The manufacturing process of a radiation-proof medical protective glove according to claim 2, characterized in that, The specific preparation steps for the semi-finished gloves are as follows: Preheat the glove mold at 60-80℃ for 25-35 minutes, then immerse the glove mold in a 2% calcium acetate solution. After removing it, dry it at 60℃ for 4-6 minutes. Next, slowly immerse it in the composite latex and gently lift it out. Initially dry it at 40℃ for 1-2 hours, then increase the temperature to 85-90℃ at a rate of 1℃ / min and cure it at 85-90℃ for 100-140 minutes. After curing, peel the glove off the mold, wash it with deionized water at 40℃, and finally dry it at 40℃ to constant weight to obtain the semi-finished glove.

5. The manufacturing process of a radiation-proof medical protective glove according to claim 4, characterized in that, The specific preparation steps of the composite latex are as follows: Natural latex was added to a reaction vessel and stirred at 400-600 r / min. Nano starch solution and sodium carboxymethyl cellulose were added to the vessel in sequence and stirred for 5 min. Then, a crosslinking agent ARK-889 solution with a pH of 10 was added and stirred for 30 min. Composite shielding microspheres were slowly added and dispersed for 10 min at 800-1000 r / min to obtain composite latex. The ratio of the amount of natural latex, nano starch solution, sodium carboxymethyl cellulose, crosslinking agent ARK-889 solution and composite shielding microspheres is 95-105mL: 4-6g: 1.5-2.5g: 5-10mL: 0.4-0.6g.

6. The manufacturing process of a radiation-proof medical protective glove according to claim 5, characterized in that, The specific preparation steps of the nano-starch solution are as follows: Tapioca starch and 25% wt ammonia water were added to a stirred tank, mixed and dispersed. Sodium hydroxide, urea and deionized water were then added to the tank. The mixture was stirred and gelatinized at 80-90℃ for 40 min. The reaction system was then transferred to an ice-water bath to cool and sonicated until the solution was clear and transparent. After equilibration to room temperature, nano starch solution was obtained. The ratio of cassava starch, ammonia, sodium hydroxide, urea, and deionized water is 8-12g: 15-25mL: 3-5g: 12-16mL: 125-140mL.

7. The manufacturing process of a radiation-proof medical protective glove according to claim 5, characterized in that, The specific preparation steps of the composite shielding microspheres are as follows: Polydopamine / bismuth oxide composite microspheres and deionized water were added to a reaction vessel and stirred at 200-400 r / min. A gadolinium nitrate solution with a concentration of 0.01 mol / L was added to the vessel and stirred continuously for 6-12 h. Samples were taken at regular intervals, and the supernatant was centrifuged to detect the gadolinium ion concentration. The reaction was terminated when the concentration reached adsorption equilibrium. After the reaction was completed, the mixture was filtered, rinsed with deionized water, and dried to obtain composite shielding microspheres. The ratio of the polydopamine / bismuth oxide composite microspheres, deionized water, and gadolinium nitrate solution is 0.25-0.35g: 180-220mL: 0.8-1.2mL.

8. The manufacturing process of a radiation-proof medical protective glove according to claim 7, characterized in that, The specific preparation steps of the polydopamine / bismuth oxide composite microspheres are as follows: Polydopamine hollow microspheres, urea, deionized water and bismuth nitrate acid solution were placed in a polytetrafluoroethylene stainless steel high-pressure reactor and reacted at 150-170℃ for 2-4 hours. After the reaction was completed, the mixture was cooled to room temperature, washed with deionized water and ethanol, centrifuged, and the filter cake was vacuum dried at 60℃ for 10-14 hours to obtain polydopamine / bismuth oxide composite microspheres. The ratio of the amount of polydopamine hollow microspheres, urea, deionized water and bismuth nitrate acidic solution is 0.1-0.2g: 0.7-0.9g: 35-45mL: 5mL.

9. The manufacturing process of a radiation-proof medical protective glove according to claim 8, characterized in that, The specific preparation steps of the polydopamine hollow microspheres are as follows: ZIF-8 powder was dispersed in methanol and added to a reaction vessel along with a 0.25 mol / L dopamine hydrochloride methanol solution. The reaction was carried out at 55°C for 4 h. After the reaction was completed, the product was centrifuged, washed with methanol, and dried under vacuum at 40°C for 10-14 h. The product was then ground and sieved to obtain polydopamine hollow microspheres. The ratio of ZIF-8 powder, methanol, and dopamine hydrochloride methanol solution is 8-12g: 650-750mL: 650-750mL.

10. A radiation-protective medical glove, characterized in that, It is produced by the production process described in any one of claims 1-9.

Citation Information

Patent Citations

  • Radiation-proof material, preparation method thereof and radiation protection sheet

    CN116444873A

Cited By

  • Radiation resistant rubber glove with antibacterial properties and method of making

    CN122188250A